公司概覽
業務類別 Medical Devices
業務概覽 One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinalfixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
公司地址 Parkmore Business Park West, Building Two, Galway, IRL, 1
電話號碼 +353 14381700
傳真號碼 --
公司網頁 https://www.medtronic.com
員工數量 95000
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Matthew R. Walter Senior Vice President and Chief Human Resources Officer -- 20/06/2025
Mr. Ivan K. Fong Executive Vice President, General Counsel and Corporate Secretary -- 20/06/2025
Mr. Michael Marinaro Executive Vice President and President, Medical Surgical Portfolio and Americas -- 20/06/2025
Ms. Denise L. Blomquist Vice President, Global Controller and Chief Accounting Officer -- 20/06/2025
Mr. Brett A. Wall Executive Vice President and President, Neuroscience Portfolio 美元 774.52K 20/06/2025
Mr. Skip Harry Kiil Executive Vice President and President, Cardiovascular Portfolio -- 21/05/2025
Mr. Geoffrey S. Martha Chief Executive Officer and Chairman of the Board 美元 1.35M 25/08/2025
Mr. Thierry Pieton Chief Financial Officer and Executive Vice President 美元 884.65K 20/06/2025
Ms. Que Thanh Dallara Chief Executive Officer, New Diabetes -- 21/05/2025
Mr. Michael Carter Senior Vice President and President, Cranial and spinal-Technologies business -- 21/05/2025
 
董事會成員
董事會 職務 更新日期
Dr. Joon Lee Independent Director 23/06/2025
Mr. Craig Arnold Lead Independent Director 25/08/2025
Mr. Kendall J. Powell Independent Director 25/08/2025
Ms. Lidia L. Fonseca Independent Director 25/08/2025
Mr. Randall J. Hogan, III Independent Director 25/08/2025
Mr. William R. Jellison Independent Director 19/08/2025
Mr. Scott C. Donnelly Independent Director 25/08/2025
Mr. John P. Groetelaars Independent Director 19/08/2025
Mr. Kevin E. Lofton Independent Director 25/08/2025
Mr. Geoffrey S. Martha Chief Executive Officer and Chairman of the Board 25/08/2025
Dr. Elizabeth G. Nabel, M.D. Independent Director 25/08/2025
Mr. Gregory P. Lewis Independent Director 25/08/2025
 
所屬ETF (更新日期: 07/03/2026 03:26)
代號 名稱 佔比% 持有日期
XYLGGlobal X S&P 500® Covered Call & Gr ETF0.0001%27/02/2026
HEQJH Diversified Income Fund0.0001%31/12/2025
JDIVJPMorgan Dividend Leaders ETF0.0001%27/02/2026
NZACState Street®SPDR®MSCIACWIClmPrsAlgndETF0.0001%27/02/2026
LCDSJPMorgan Fundamental Data Sci Lg Cor ETF0.0001%27/02/2026
JUSAJPMorgan ActiveBuilders US Lg Cp Eq ETF0.0001%31/08/2023
PHDGInvesco S&P 500® Downside Hedged ETF0.0001%27/02/2026
QWLDState Street® SPDR® MSCI Wld StrtFcs ETF0.0001%27/02/2026
XRMIGlobal X S&P 500® Risk Managed Inc ETF0.0001%27/02/2026
ESLVEventide Large Cap Value ETF0.0001%27/02/2026
AAEQAlpha Architect US Equity 2 ETF0.0001%22/01/2026
GENDGenter Capital Dividend Income ETF0.0001%27/02/2026
URSPProShares Ultra S&P 500 Equal Weight0.0001%30/11/2025
TMDVProShares Russell US Dividend Grwr ETF0.0001%27/02/2026
QRFTQRAFT AI-Enhanced US Large Cap ETF0.00004%27/02/2026
SNPDXtrackers S&P Div Arstcrts Scrn ETF0.00004%26/02/2026
XUDVFranklin U.S. Dividend Bstr Idx ETF0.00004%27/02/2026
JFLIJPMorgan Flexible Income ETF0.00004%27/02/2026
JHDVJHancock U.S. High Dividend ETF0.00003%27/02/2026
MDEVFirst Trust Indxx Global Mdcl Dvcs ETF0.00003%26/02/2026
  1    2    3    4    5    6    7    8    9    10    11    12    13   14    15    16    17    18    19  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.